In addition, B-cell-restricted expression of Lmo2 reprograms committed B-cells into malignant T-ALL [141], demonstrating the proof of concept that a primary oncogene can induce sufficient reprogramming to switch from a B-cell fate to a T-cell neoplastic process. Here, LMO2 is linked to acute lymphoblastic leukemia.